Chularat Hospital PCL (BKK: CHG)
Thailand
· Delayed Price · Currency is THB
2.480
+0.020 (0.81%)
Dec 20, 2024, 4:36 PM ICT
Chularat Hospital PCL Income Statement
Financials in millions THB. Fiscal year is January - December.
Millions THB. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Operating Revenue | 8,439 | 7,730 | 10,103 | 11,742 | 5,433 | 5,166 | Upgrade
|
Other Revenue | 294.84 | 284.13 | 304.57 | 257.29 | 28.86 | 22.09 | Upgrade
|
Revenue | 8,733 | 8,014 | 10,408 | 11,999 | 5,462 | 5,188 | Upgrade
|
Revenue Growth (YoY) | 14.26% | -23.00% | -13.27% | 119.70% | 5.28% | 17.17% | Upgrade
|
Cost of Revenue | 6,229 | 5,723 | 5,908 | 5,882 | 3,685 | 3,629 | Upgrade
|
Gross Profit | 2,504 | 2,292 | 4,500 | 6,117 | 1,777 | 1,558 | Upgrade
|
Selling, General & Admin | 985.73 | 910.77 | 934.88 | 821.27 | 673.2 | 672.38 | Upgrade
|
Operating Expenses | 985.73 | 910.77 | 934.88 | 821.27 | 673.2 | 672.38 | Upgrade
|
Operating Income | 1,518 | 1,381 | 3,565 | 5,296 | 1,104 | 885.95 | Upgrade
|
Interest Expense | -34.87 | -24 | -16.28 | -21.38 | -35.64 | -40.45 | Upgrade
|
Interest & Investment Income | 11.58 | 8.66 | 6.08 | 1.9 | 2.77 | 3.16 | Upgrade
|
Earnings From Equity Investments | -21.12 | -19.35 | -1.11 | - | - | - | Upgrade
|
Pretax Income | 1,474 | 1,346 | 3,554 | 5,276 | 1,071 | 848.67 | Upgrade
|
Income Tax Expense | 308.24 | 279.09 | 703.37 | 1,009 | 218.73 | 184 | Upgrade
|
Earnings From Continuing Operations | 1,166 | 1,067 | 2,850 | 4,267 | 852.36 | 664.66 | Upgrade
|
Minority Interest in Earnings | -18.17 | -21.21 | -71.68 | -63.22 | 24.26 | 40.57 | Upgrade
|
Net Income | 1,147 | 1,046 | 2,778 | 4,204 | 876.62 | 705.24 | Upgrade
|
Net Income to Common | 1,147 | 1,046 | 2,778 | 4,204 | 876.62 | 705.24 | Upgrade
|
Net Income Growth | 8.50% | -62.35% | -33.91% | 379.58% | 24.30% | 11.26% | Upgrade
|
Shares Outstanding (Basic) | 11,000 | 11,000 | 11,000 | 11,000 | 11,000 | 11,000 | Upgrade
|
Shares Outstanding (Diluted) | 11,000 | 11,000 | 11,000 | 11,000 | 11,000 | 11,000 | Upgrade
|
EPS (Basic) | 0.10 | 0.10 | 0.25 | 0.38 | 0.08 | 0.06 | Upgrade
|
EPS (Diluted) | 0.10 | 0.10 | 0.25 | 0.38 | 0.08 | 0.06 | Upgrade
|
EPS Growth | 8.50% | -62.35% | -33.91% | 379.58% | 24.30% | 11.26% | Upgrade
|
Free Cash Flow | 1,210 | 959.3 | 1,843 | 3,525 | 1,008 | 263.67 | Upgrade
|
Free Cash Flow Per Share | 0.11 | 0.09 | 0.17 | 0.32 | 0.09 | 0.02 | Upgrade
|
Dividend Per Share | 0.070 | 0.070 | 0.160 | 0.200 | 0.050 | 0.050 | Upgrade
|
Dividend Growth | -26.32% | -56.25% | -20.00% | 300.00% | 0% | 0% | Upgrade
|
Gross Margin | 28.67% | 28.60% | 43.23% | 50.98% | 32.54% | 30.04% | Upgrade
|
Operating Margin | 17.38% | 17.23% | 34.25% | 44.13% | 20.21% | 17.08% | Upgrade
|
Profit Margin | 13.14% | 13.05% | 26.70% | 35.04% | 16.05% | 13.59% | Upgrade
|
Free Cash Flow Margin | 13.85% | 11.97% | 17.71% | 29.38% | 18.46% | 5.08% | Upgrade
|
EBITDA | 1,980 | 1,790 | 3,921 | 5,623 | 1,437 | 1,211 | Upgrade
|
EBITDA Margin | 22.67% | 22.34% | 37.67% | 46.86% | 26.32% | 23.35% | Upgrade
|
D&A For EBITDA | 461.26 | 409.41 | 355.71 | 327.11 | 333.37 | 325.27 | Upgrade
|
EBIT | 1,518 | 1,381 | 3,565 | 5,296 | 1,104 | 885.95 | Upgrade
|
EBIT Margin | 17.38% | 17.23% | 34.25% | 44.13% | 20.21% | 17.08% | Upgrade
|
Effective Tax Rate | 20.91% | 20.73% | 19.79% | 19.12% | 20.42% | 21.68% | Upgrade
|
Revenue as Reported | 8,733 | 8,014 | 10,408 | 11,999 | 5,462 | 5,188 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.